A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary.
Is there an alternative?
December 18, 2018
Leveraging New Technologies for Better Diabetes Care
January 24, 2017
Diabetes Monitoring and Diagnosis Beyond A1c
January 18, 2017
November is American Diabetes Month
November 28, 2016
Epinex Diagnostics Enters Digital Health Field –Launches “Am I Diabetic” Mobile Phone App
November 17, 2016
November 30, 2015
"A beta cell defect is responsible for the development ofprediabetes and type 2 diabetes in people from East Asia, according to new research.
The study, conducted at the Seoul National University College of Medicine, South Korea, used oral glucose tolerance tests to examine pancreatic beta cell function and insulin sensitivity."
Click here to read the full article
Type 2 diabetes
A new utility of glycated albumin in monitoring car...
Epinex’s Research Paper Reaches New Milestone
Epinex at the 2017 AACC Conference
Beyond A1C: Glycated Albumin Takes Center Stage at...
Amidst Healthcare Chaos, California Authorizes a Ne...
A new article in JAMA reports self-blood glucose mo...
Plug and Play Tech Center
Asad Zaidi CEO of Epinex Diagnostic Inc. will atten...
Glycated Albumin used in measuring ‘Stress Diabetes...
A potential role of glycated albumin as a marker fo...